REGENTIS BIOMATERIALS LTD., 2026-06-25
An SEC Form D private-offering notice from Herzliya, a $6,500,000 filer-stated offering target in Biotech. Filed 2026-06-25. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Israeli developer of Gelrin, a degradable hydrogel implant platform for orthopedic tissue repair, whose lead product GelrinC treats knee cartilage injuries.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Exactics, Inc., 2026-06-25, $1.5M, Chicago, IL
- NEONC TECHNOLOGIES HOLDINGS, INC., 2026-06-25, $5M, Calabasas, CA
- Lycia Therapeutics, Inc., 2026-06-25, $75M, South San Francisco, CA
- IceCure Medical Ltd., 2026-06-25, $16.5M, Caesarea
- Boston Interactome, Inc., 2026-06-24, $1.5M, Allston, MA
- YUTIDETX INC., 2026-06-24, $375K, Arlington, VA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.